<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.globalizationandhealth.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Globalization and Health - Most accessed articles</title>
        <link>http://www.globalizationandhealth.com</link>
        <description>The most accessed research articles published by Globalization and Health</description>
        <dc:date>2012-04-25T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/1/1/14" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/8/1/8" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/2/1/4" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/1/1/13" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/8/1/9" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/2/1/9" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/7/1/12" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/7/1/26" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/6/1/16" />
                                <rdf:li rdf:resource="http://www.globalizationandhealth.com/content/3/1/5" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.globalizationandhealth.com/content/1/1/14">
        <title>The health impacts of globalisation: a conceptual framework</title>
        <description>This paper describes a conceptual framework for the health implications of globalisation. The framework is developed by first identifying the main determinants of population health and the main features of the globalisation process. The resulting conceptual model explicitly visualises that globalisation affects the institutional, economic, social-cultural and ecological determinants of population health, and that the globalisation process mainly operates at the contextual level, while influencing health through its more distal and proximal determinants. The developed framework provides valuable insights in how to organise the complexity involved in studying the health effects resulting from globalisation. It could, therefore, give a meaningful contribution to further empirical research by serving as a &apos;think-model&apos; and provides a basis for the development of future scenarios on health.</description>
        <link>http://www.globalizationandhealth.com/content/1/1/14</link>
                <dc:creator>Maud Huynen</dc:creator>
                <dc:creator>Pim Martens</dc:creator>
                <dc:creator>Henk Hilderink</dc:creator>
                <dc:source>Globalization and Health 2005, null:14</dc:source>
        <dc:date>2005-08-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-1-14</dc:identifier>
                                <prism:require>/content/figures/1744-8603-1-14-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2005-08-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/8/1/8">
        <title>Global health funding and economic development</title>
        <description>The impact of increased national wealth, as measured by Gross Domestic Product (GDP), on public health is widely understood, however an equally important but less well-acclaimed relationship exists between improvements in health and the growth of an economy. Communicable diseases such as HIV, TB, Malaria and the Neglected Tropical Diseases (NTDs) are impacting many of the world&apos;s poorest and most vulnerable populations, and depressing economic development. Sickness and disease has decreased the size and capabilities of the workforce through impeding access to education and suppressing foreign direct investment (FDI). There is clear evidence that by investing in health improvements a significant increase in GDP per capita can be attained in four ways: Firstly, healthier populations are more economically productive; secondly, proactive healthcare leads to decrease in many of the additive healthcare costs associated with lack of care (treating opportunistic infections in the case of HIV for example); thirdly, improved health represents a real economic and developmental outcome in-and-of itself and finally, healthcare spending capitalises on the Keynesian &apos;economic multiplier&apos; effect. Continued under-investment in health and health systems represent an important threat to our future global prosperity. This editorial calls for a recognition of health as a major engine of economic growth and for commensurate investment in public health, particularly in poor countries.</description>
        <link>http://www.globalizationandhealth.com/content/8/1/8</link>
                <dc:creator>Greg Martin</dc:creator>
                <dc:creator>Alexandrea Grant</dc:creator>
                <dc:creator>Mark D'Agostino</dc:creator>
                <dc:source>Globalization and Health 2012, null:8</dc:source>
        <dc:date>2012-04-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-8-8</dc:identifier>
                                <prism:require>/content/figures/1744-8603-8-8-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2012-04-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/2/1/4">
        <title>Uneven dietary development: linking the policies and processes of globalization with the nutrition transition, obesity and diet-related chronic diseases</title>
        <description>In a &quot;nutrition transition&quot;, the consumption of foods high in fats and sweeteners is increasing throughout the developing world. The transition, implicated in the rapid rise of obesity and diet-related chronic diseases worldwide, is rooted in the processes of globalization. Globalization affects the nature of agri-food systems, thereby altering the quantity, type, cost and desirability of foods available for consumption. Understanding the links between globalization and the nutrition transition is therefore necessary to help policy makers develop policies, including food policies, for addressing the global burden of chronic disease. While the subject has been much discussed, tracing the specific pathways between globalization and dietary change remains a challenge.To help address this challenge, this paper explores how one of the central mechanisms of globalization, the integration of the global marketplace, is affecting the specific diet patterns. Focusing on middle-income countries, it highlights the importance of three major processes of market integration: (I) production and trade of agricultural goods; (II) foreign direct investment in food processing and retailing; and (III) global food advertising and promotion.The paper reveals how specific policies implemented to advance the globalization agenda account in part for some recent trends in the global diet. Agricultural production and trade policies have enabled more vegetable oil consumption; policies on foreign direct investment have facilitated higher consumption of highly-processed foods, as has global food marketing. These dietary outcomes also reflect the socioeconomic and cultural context in which these policies are operating.An important finding is that the dynamic, competitive forces unleashed as a result of global market integration facilitates not only convergence in consumption habits (as is commonly assumed in the &quot;Coca-Colonization&quot; hypothesis), but adaptation to products targeted at different niche markets. This convergence-divergence duality raises the policy concern that globalization will exacerbate uneven dietary development between rich and poor. As high-income groups in developing countries accrue the benefits of a more dynamic marketplace, lower-income groups may well experience convergence towards poor quality obseogenic diets, as observed in western countries.Global economic polices concerning agriculture, trade, investment and marketing affect what the world eats. They are therefore also global food and health policies. Health policy makers should pay greater attention to these policies in order to address some of the structural causes of obesity and diet-related chronic diseases worldwide, especially among the groups of low socioeconomic status.</description>
        <link>http://www.globalizationandhealth.com/content/2/1/4</link>
                <dc:creator>Corinna Hawkes</dc:creator>
                <dc:source>Globalization and Health 2006, null:4</dc:source>
        <dc:date>2006-03-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-2-4</dc:identifier>
                                <prism:require>/content/figures/1744-8603-2-4-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2006-03-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/1/1/13">
        <title>HIV/AIDS: global trends, global funds and delivery bottlenecks</title>
        <description>Globalisation affects all facets of human life, including health and well being. The HIV/AIDS epidemic has highlighted the global nature of human health and welfare and globalisation has given rise to a trend toward finding common solutions to global health challenges. Numerous international funds have been set up in recent times to address global health challenges such as HIV.However, despite increasingly large amounts of funding for health initiatives being made available to poorer regions of the world, HIV infection rates and prevalence continue to increase world wide. As a result, the AIDS epidemic is expanding and intensifying globally. Worst affected are undoubtedly the poorer regions of the world as combinations of poverty, disease, famine, political and economic instability and weak health infrastructure exacerbate the severe and far-reaching impacts of the epidemic.One of the major reasons for the apparent ineffectiveness of global interventions is historical weaknesses in the health systems of underdeveloped countries, which contribute to bottlenecks in the distribution and utilisation of funds. Strengthening these health systems, although a vital component in addressing the global epidemic, must however be accompanied by mitigation of other determinants as well. These are intrinsically complex and include social and environmental factors, sexual behaviour, issues of human rights and biological factors, all of which contribute to HIV transmission, progression and mortality. An equally important factor is ensuring an equitable balance between prevention and treatment programmes in order to holistically address the challenges presented by the epidemic.</description>
        <link>http://www.globalizationandhealth.com/content/1/1/13</link>
                <dc:creator>Hoosen Coovadia</dc:creator>
                <dc:creator>Jacqui Hadingham</dc:creator>
                <dc:source>Globalization and Health 2005, null:13</dc:source>
        <dc:date>2005-08-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-1-13</dc:identifier>
                                <prism:require>/content/figures/1744-8603-1-13-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2005-08-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/8/1/9">
        <title>The Economic Impact of Non-communicable Diseases on Households in India</title>
        <description>Background:
In India, Non Communicable Diseases (NCDs) and injuries account for an estimated 62% of the total age-standardized burden of forgone Disability Adjusted Life Years (DALYs). Public and private financing of clinical services to reduce the NCD burden is a major challenge.
Methods:
We used National Sample Survey Organization (NSSO) survey data from 1995-96 and 2004 covering nearly 200 thousand households to assess healthcare utilization patterns and out of pocket health spending by disease category. For this purpose, self-reported diseases and conditions were categorized into NCDs and non-NCDs. Survey data were used to assess how households financed their overall health expenditures and related this pattern to specific health conditions. We measured catastrophic spending on NCD-related hospitalization, defined as occurring when health expenditures exceeded 40% of a household&apos;s ability to pay, that is, household consumption spending less combined survival consumption expenditure; and impoverishment when per capita expenditure within the household decreased to below the poverty line once health spending was netted out.
Results:
The share of NCDs in out of pocket health expenses incurred by households increased over time, from 31.6 percent in 1995-96 to 47.3 percent in 2004. In both years, own savings and income were the most important source of financing for many health conditions, typically between 40-60 percent of all spending, whereas 30-35 percent was from borrowing. The odds of catastrophic hospitalization expenditures for cancer was nearly 170% greater and for CVD and injuries 22 percent greater than the odds due to communicable diseases. Impoverishment patterns were similar.
Conclusions:
Out of pocket expenses for treating NCDs rose sharply over the period from 1995-96 to 2004. When NCDs are present, the financial risks to which Indians households are exposed are significant.</description>
        <link>http://www.globalizationandhealth.com/content/8/1/9</link>
                <dc:creator>Michael Engelgau</dc:creator>
                <dc:creator>Anup Karan</dc:creator>
                <dc:creator>Ajay Mahal</dc:creator>
                <dc:source>Globalization and Health 2012, null:9</dc:source>
        <dc:date>2012-04-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-8-9</dc:identifier>
                                <prism:require>/content/figures/1744-8603-8-9-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2012-04-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/2/1/9">
        <title>Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries?</title>
        <description>Background:
The ongoing policy debate about the value of communications technology in promoting development objectives is diverse. Some view computer/web/phone communications technology as insufficient to solve development problems while others view communications technology as assisting all sections of the population. This paper looks at evidence to support or refute the idea that fixed and mobile telephones is, or could be, an effective healthcare intervention in developing countries.
Methods:
A Web-based and library database search was undertaken including the following databases: MEDLINE, CINAHL, (nursing &amp; allied health), Evidence Based Medicine (EBM), POPLINE, BIOSIS, and Web of Science, AIDSearch (MEDLINE AIDS/HIV Subset, AIDSTRIALS &amp; AIDSDRUGS) databases.
Results:
Evidence can be found to both support and refute the proposition that fixed and mobile telephones is, or could be, an effective healthcare intervention in developing countries. It is difficult to generalize because of the different outcome measurements and the small number of controlled studies. There is almost no literature on using mobile telephones as a healthcare intervention for HIV, TB, malaria, and chronic conditions in developing countries. Clinical outcomes are rarely measured. Convincing evidence regarding the overall cost-effectiveness of mobile phone &quot; telemedicine&quot; is still limited and good-quality studies are rare. Evidence of the cost effectiveness of such interventions to improve adherence to medicines is also quite weak.
Conclusion:
The developed world model of personal ownership of a phone may not be appropriate to the developing world in which shared mobile telephone use is important. Sharing may be a serious drawback to use of mobile telephones as a healthcare intervention in terms of stigma and privacy, but its magnitude is unknown. One advantage, however, of telephones with respect to adherence to medicine in chronic care models is its ability to create a multi-way interaction between patient and provider(s) and thus facilitate the dynamic nature of this relationship. Regulatory reforms required for proper operation of basic and value-added telecommunications services are a priority if mobile telecommunications are to be used for healthcare initiatives.</description>
        <link>http://www.globalizationandhealth.com/content/2/1/9</link>
                <dc:creator>Warren Kaplan</dc:creator>
                <dc:source>Globalization and Health 2006, null:9</dc:source>
        <dc:date>2006-05-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-2-9</dc:identifier>
                                <prism:require>/content/figures/1744-8603-2-9-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2006-05-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/7/1/12">
        <title>Medical tourism and policy implications for health systems: a conceptual framework from a comparative study of Thailand, Singapore and Malaysia
</title>
        <description>Medical tourism is a growing phenomenon with policy implications for health systems, particularly of destination countries. Private actors and governments in Southeast Asia are promoting the medical tourist industry, but the potential impact on health systems, particularly in terms of equity in access and availability for local consumers, is unclear. This article presents a conceptual framework that outlines the policy implications of medical tourism&apos;s growth for health systems, drawing on the cases of Thailand, Singapore and Malaysia, three regional hubs for medical tourism, via an extensive review of academic and grey literature. Variables for further analysis of the potential impact of medical tourism on health systems are also identified. The framework can provide a basis for empirical, in country studies weighing the benefits and disadvantages of medical tourism for health systems. The policy implications described are of particular relevance for policymakers and industry practitioners in other Southeast Asian countries with similar health systems where governments have expressed interest in facilitating the growth of the medical tourist industry. This article calls for a universal definition of medical tourism and medical tourists to be enunciated, as well as concerted data collection efforts, to be undertaken prior to any meaningful empirical analysis of medical tourism&apos;s impact on health systems.</description>
        <link>http://www.globalizationandhealth.com/content/7/1/12</link>
                <dc:creator>Nicola Pocock</dc:creator>
                <dc:creator>Kai Hong Phua</dc:creator>
                <dc:source>Globalization and Health 2011, null:12</dc:source>
        <dc:date>2011-05-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-7-12</dc:identifier>
                                <prism:require>/content/figures/1744-8603-7-12-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2011-05-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/7/1/26">
        <title>Major Multinational Food and Beverage Companies and Informal Sector Contributions to Global Food Consumption: Implications for Nutrition Policy</title>
        <description>Background:
In recent years, 10 major multinational food and beverage companies have worked together within the International Food and Beverage Alliance (IFBA) to increase their commitments to public health. Current IFBA commitments include initiatives to improve the nutrition quality of products and how these products are advertised to children. The impact and magnitude of IFBA member contributions to the total market share of packaged foods and beverages consumed remain incompletely understood, however.
Methods:
In order to evaluate this impact, we examined packaged food and soft drink company shares provided by Euromonitor, an international independent market analysis company. Packaged foods include baby food, bakery, canned/preserved food, chilled/processed food, confectionery, dairy, dried processed food, frozen processed food, ice cream, meal replacement, noodles, oils and fats, pasta, ready meals, sauces, dressings and condiments, snack bars, soup, spreads, and sweet and savoury snacks. Soft drinks include carbonates, packaged fruit/vegetable juice, bottled water, functional drinks, concentrates, ready-to-drink tea, ready-to-drink coffee and Asian specialty drinks. We calculated the market shares for IFBA companies, globally and within nine countries--the US, China, India, Egypt, South Africa, Brazil, Mexico, Turkey and the UK.
Results:
Worldwide, the top ten packaged food companies account for 15.2% of sales, with each individual company contributing less than 3.3%. The top ten soft drink companies account for 52.3% of sales worldwide; Coca-Cola and PepsiCo lead with 25.9% and 11.5% of sales, respectively.
Conclusions:
Although the top ten soft drink companies account for half of global sales, the top ten packaged food companies account for only a small proportion of market share with most individual companies contributing less than 3.3% each. Major multinational companies need to be joined by the myriad of small- and medium-sized enterprises in developing and implementing programs to improve the health of the public, globally. Without full participation of these companies, the impact of commitments made by IFBA members and other major multinational food and beverage companies will remain limited.</description>
        <link>http://www.globalizationandhealth.com/content/7/1/26</link>
                <dc:creator>Eleanore Alexander</dc:creator>
                <dc:creator>Derek Yach</dc:creator>
                <dc:creator>George Mensah</dc:creator>
                <dc:source>Globalization and Health 2011, null:26</dc:source>
        <dc:date>2011-08-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-7-26</dc:identifier>
                                <prism:require>/content/figures/1744-8603-7-26-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>26</prism:startingPage>
        <prism:publicationDate>2011-08-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/6/1/16">
        <title>Is globalization healthy: a statistical indicator analysis of the impacts of globalization on health
</title>
        <description>It is clear that globalization is something more than a purely economic phenomenon manifesting itself on a global scale. Among the visible manifestations of globalization are the greater international movement of goods and services, financial capital, information and people. In addition, there are technological developments, more transboundary cultural exchanges, facilitated by the freer trade of more differentiated products as well as by tourism and immigration, changes in the political landscape and ecological consequences. In this paper, we link the Maastricht Globalization Index with health indicators to analyse if more globalized countries are doing better in terms of infant mortality rate, under-five mortality rate, and adult mortality rate. The results indicate a positive association between a high level of globalization and low mortality rates. In view of the arguments that globalization provides winners and losers, and might be seen as a disequalizing process, we should perhaps be careful in interpreting the observed positive association as simple evidence that globalization is mostly good for our health. It is our hope that a further analysis of health impacts of globalization may help in adjusting and optimising the process of globalization on every level in the direction of a sustainable and healthy development for all.</description>
        <link>http://www.globalizationandhealth.com/content/6/1/16</link>
                <dc:creator>Pim Martens</dc:creator>
                <dc:creator>Su-Mia Akin</dc:creator>
                <dc:creator>Maud Huynen</dc:creator>
                <dc:creator>Mohsin Raza</dc:creator>
                <dc:source>Globalization and Health 2010, null:16</dc:source>
        <dc:date>2010-09-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-6-16</dc:identifier>
                                <prism:require>/content/figures/1744-8603-6-16-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2010-09-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.globalizationandhealth.com/content/3/1/5">
        <title>Globalization and social determinants of health: Introduction and methodological background (part 1 of 3)

</title>
        <description>Globalization is a key context for the study of social determinants of health (SDH). Broadly stated, SDH are the conditions in which people live and work, and that affect their opportunities to lead healthy lives.In this first article of a three-part series, we describe the origins of the series in work conducted for the Globalization Knowledge Network of the World Health Organization&apos;s Commission on Social Determinants of Health and in the Commission&apos;s specific concern with health equity. We explain our rationale for defining globalization with reference to the emergence of a global marketplace, and the economic and political choices that have facilitated that emergence. We identify a number of conceptual milestones in studying the relation between globalization and SDH over the period 1987&#8211;2005, and then show that because globalization comprises multiple, interacting policy dynamics, reliance on evidence from multiple disciplines (transdisciplinarity) and research methodologies is required. So, too, is explicit recognition of the uncertainties associated with linking globalization &#8211; the quintessential &quot;upstream&quot; variable &#8211; with changes in SDH and in health outcomes.</description>
        <link>http://www.globalizationandhealth.com/content/3/1/5</link>
                <dc:creator>Ronald Labonte</dc:creator>
                <dc:creator>Ted Schrecker</dc:creator>
                <dc:source>Globalization and Health 2007, null:5</dc:source>
        <dc:date>2007-06-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1744-8603-3-5</dc:identifier>
                                <prism:require>/content/figures/1744-8603-3-5-toc.gif</prism:require>
                <prism:publicationName>Globalization and Health</prism:publicationName>
        <prism:issn>1744-8603</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2007-06-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

